T1	Participants 79 102	rheumatic arthropathies
T2	Participants 261 338	patients suffering from inflammatory and degenerative rheumatic arthropathies
T3	Participants 369 530	30 subjects using the controlled experiment technique according to the "between patient" pattern, attributing parsalmide and indomethacin at random to two groups
